142 related articles for article (PubMed ID: 29885296)
1. Anticonvulsant agent DPP4 inhibitor sitagliptin downregulates CXCR3/RAGE pathway on seizure models.
Liu Y; Hou B; Zhang Y; Fan Y; Peng B; Liu W; Han S; Yin J; He X
Exp Neurol; 2018 Sep; 307():90-98. PubMed ID: 29885296
[TBL] [Abstract][Full Text] [Related]
2. Sitagliptin attenuates arterial calcification by downregulating oxidative stress-induced receptor for advanced glycation end products in LDLR knockout mice.
Lin CP; Huang PH; Chen CY; Wu MY; Chen JS; Chen JW; Lin SJ
Sci Rep; 2021 Sep; 11(1):17851. PubMed ID: 34497344
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of DPP4 enhances inhibitory synaptic transmission through activating the GLP-1/GLP-1R signaling pathway in a rat model of febrile seizures.
Zhang Y; Liu Y; Xu J; Sun Q; Yu F; Cheng J; Peng B; Liu W; Xiao Z; Yin J; Han S; He X
Biochem Pharmacol; 2018 Oct; 156():78-85. PubMed ID: 30086287
[TBL] [Abstract][Full Text] [Related]
4. DPP4 regulates the inflammatory response in a rat model of febrile seizures.
Sun Q; Zhang Y; Huang J; Yu F; Xu J; Peng B; Liu W; Han S; Yin J; He X
Biomed Mater Eng; 2017; 28(s1):S139-S152. PubMed ID: 28372289
[TBL] [Abstract][Full Text] [Related]
5. Suppression of BACE1 and amyloidogenic/RAGE axis by sitagliptin ameliorates PTZ kindling-induced cognitive deficits in rats.
Safar MM; Shahin NN; Mohamed AF; Abdelkader NF
Chem Biol Interact; 2020 Sep; 328():109144. PubMed ID: 32653415
[TBL] [Abstract][Full Text] [Related]
6. Anti-Inflammatory Action of Sitagliptin and Linagliptin in Doxorubicin Nephropathy.
Jo CH; Kim S; Park JS; Kim GH
Kidney Blood Press Res; 2018; 43(3):987-999. PubMed ID: 29913457
[TBL] [Abstract][Full Text] [Related]
7. Effects of dipeptidyl peptidase-4 inhibitors on transforming growth factor-β1 signal transduction pathways in the ovarian fibrosis of polycystic ovary syndrome rats.
Wang F; Zhang ZF; He YR; Wu HY; Wei SS
J Obstet Gynaecol Res; 2019 Mar; 45(3):600-608. PubMed ID: 30515927
[TBL] [Abstract][Full Text] [Related]
8. Sitagliptin ameliorates renal tubular injury in diabetic kidney disease via STAT3-dependent mitochondrial homeostasis through SDF-1α/CXCR4 pathway.
Zhang Q; He L; Dong Y; Fei Y; Wen J; Li X; Guan J; Liu F; Zhou T; Li Z; Fan Y; Wang N
FASEB J; 2020 Jun; 34(6):7500-7519. PubMed ID: 32281218
[TBL] [Abstract][Full Text] [Related]
9. The effect of dipeptidyl peptidase IV on disease-associated microglia phenotypic transformation in epilepsy.
Zheng Z; Liang P; Hou B; Lu X; Ma Q; Yu X; Han S; Peng B; Chen T; Liu W; Yin J; He X
J Neuroinflammation; 2021 May; 18(1):112. PubMed ID: 33975617
[TBL] [Abstract][Full Text] [Related]
10. Effect of dipeptidyl peptidase 4 inhibition on arterial blood pressure is context dependent.
Jackson EK; Mi Z; Tofovic SP; Gillespie DG
Hypertension; 2015 Jan; 65(1):238-49. PubMed ID: 25368027
[TBL] [Abstract][Full Text] [Related]
11. Sitagliptin Mitigates Total Body Irradiation-Induced Hematopoietic Injury in Mice.
Wang M; Dong Y; Wu J; Li H; Zhang J; Lu L; Zhang Y; Zhou Z; Fan S; Li D; Meng A
Oxid Med Cell Longev; 2020; 2020():8308616. PubMed ID: 32774687
[TBL] [Abstract][Full Text] [Related]
12. Urinary DPP4 correlates with renal dysfunction, and DPP4 inhibition protects against the reduction in megalin and podocin expression in experimental CKD.
Benetti A; Martins FL; Sene LB; Shimizu MHM; Seguro AC; Luchi WM; Girardi ACC
Am J Physiol Renal Physiol; 2021 Mar; 320(3):F285-F296. PubMed ID: 33346727
[TBL] [Abstract][Full Text] [Related]
13. Thymoquinone and vitamin C attenuates pentylenetetrazole-induced seizures via activation of GABAB1 receptor in adult rats cortex and hippocampus.
Ullah I; Badshah H; Naseer MI; Lee HY; Kim MO
Neuromolecular Med; 2015 Mar; 17(1):35-46. PubMed ID: 25429759
[TBL] [Abstract][Full Text] [Related]
14. The mechanism of sitagliptin inhibition of colorectal cancer cell lines' metastatic functionalities.
Varela-Calviño R; Rodríguez-Quiroga M; Dias Carvalho P; Martins F; Serra-Roma A; Vázquez-Iglesias L; Páez de la Cadena M; Velho S; Cordero OJ
IUBMB Life; 2021 May; 73(5):761-773. PubMed ID: 33615655
[TBL] [Abstract][Full Text] [Related]
15. Sitagliptin alleviated myocardial remodeling of the left ventricle and improved cardiac diastolic dysfunction in diabetic rats.
Liu YS; Huang ZW; Wang L; Liu XX; Wang YM; Zhang Y; Zhang M
J Pharmacol Sci; 2015 Mar; 127(3):260-74. PubMed ID: 25837922
[TBL] [Abstract][Full Text] [Related]
16. Sitagliptin inhibits endothelin-1 expression in the aortic endothelium of rats with streptozotocin-induced diabetes by suppressing the nuclear factor-κB/IκBα system through the activation of AMP-activated protein kinase.
Tang ST; Su H; Zhang Q; Tang HQ; Wang CJ; Zhou Q; Wei W; Zhu HQ; Wang Y
Int J Mol Med; 2016 Jun; 37(6):1558-66. PubMed ID: 27122056
[TBL] [Abstract][Full Text] [Related]
17. DPP-4 (CD26) inhibitor sitagliptin exerts anti-inflammatory effects on rat insulinoma (RINm) cells via suppressing NF-κB activation.
Hu X; Liu S; Liu X; Zhang J; Liang Y; Li Y
Endocrine; 2017 Mar; 55(3):754-763. PubMed ID: 27612849
[TBL] [Abstract][Full Text] [Related]
18. Glycosaminoglycans Regulate CXCR3 Ligands at Distinct Levels: Protection against Processing by Dipeptidyl Peptidase IV/CD26 and Interference with Receptor Signaling.
Metzemaekers M; Mortier A; Janssens R; Boff D; Vanbrabant L; Lamoen N; Van Damme J; Teixeira MM; De Meester I; Amaral FA; Proost P
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28703769
[TBL] [Abstract][Full Text] [Related]
19. Transcriptome analysis of the hippocampus in novel rat model of febrile seizures.
Wang Z; Fan Y; Xu J; Li L; Heng D; Han S; Yin J; Peng B; Liu W; He X
PLoS One; 2014; 9(4):e95237. PubMed ID: 24736375
[TBL] [Abstract][Full Text] [Related]
20. Sitagliptin: a potential drug for the treatment of COVID-19?
Bardaweel SK; Hajjo R; Sabbah DA
Acta Pharm; 2021 Jun; 71(2):175-184. PubMed ID: 33151168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
